Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients
Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection
|3||Enrolling by invitation||
Clinical and Virological Outcome of European Patients Infected With HIV
† Study has passed its completion date and status has not been verified in more than two years.